Xenical OTC Actual Use Trial Shows Dose Compliance, Glaxo Says
This article was originally published in The Tan Sheet
Executive Summary
Only a single consumer reported exceeding Xenical dose guidelines in a 237-person actual use trial of the weight-loss drug, Glaxo researchers report
You may also be interested in...
Xenical Study Supports Proposed Nonprescription Dose, Glaxo Says
The "behavior modification" effect ofXenical adverse events could help allay concerns that OTC availability would lead to people using orlistat without making appropriate adjustments to their diets, according to the principal investigator of a study on the drug
Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.
Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.